None listed
Conditions
Interventions
Intervention1: Evaluating the effectiveness of Novel Mosquito repellent cream using Tagetes erecta, C pulcherima and trans cinnamaldhyde for personal protection in rural population of Trivallur distri
Sponsors
Saveetha Medical College and Hospital
Eligibility
Inclusion criteria
Inclusion criteria: 18 to 60 years of aged adults
Exclusion criteria
Exclusion criteria: Children Pregnant mothers Anyone with the history of skin lesions
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Complete Protection Time (CPT): Time (in minutes/hours) between application of the repellent and the first mosquito landing or probing on treated skin Landing Rate Reduction (Biting Index)Timepoint: Complete Protection Time (CPT): Time (in minutes/hours) between application of the repellent and the first mosquito landing or probing on treated skin Landing Rate Reduction (Biting Index) | — |
Secondary
| Measure | Time frame |
|---|---|
| Landing Rate Reduction (Biting Index) Percentage protection Species landing index Skin irritation or adverse events Acceptability Timepoint: 1. Landing Rate (Biting Index) Time points: At minutes 15, 30, and 45 of every hour after repellent application Continues until the first mosquito landing/probing occurs (CPT) or up to 12 hours maximum Recorded during each session (herbal, DEET, placebo) 2. Percentage Protection (%) Time points: Calculated hourly using landing counts Based on the same collection intervals: 15, 30, 45 min per hour Continues until CPT or up to 12 hours 3. Species-Specific Landing Count (Aedes, Culex, Anopheles) Time points: Species identification performed for each 1-minute catch At 15, 30, 45 min every hour until CPT or up to 12 hours 4. Skin Irritation / Adverse Events Time points: Before repellent application Immediately after session completion At 24 hours post-application (to check delayed reactions) 5. Acceptability (Odour, Feel, Comfort, Willingness to Reuse) Time points: Immediately after each testing session (each of the 3 crossover sessions) One short questionnaire per session | — |
Countries
India
Contacts
Public ContactDr Tharani Vasudevan
Saveetha Medical College and Hospital
Outcome results
None listed